SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-026977
Filing Date
2022-02-03
Accepted
2022-02-03 16:06:11
Documents
12
Period of Report
2022-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d303262d8k.htm   iXBRL 8-K 21348
  Complete submission text file 0001193125-22-026977.txt   145176

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA annx-20220201.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20220201_lab.xml EX-101.LAB 18757
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20220201_pre.xml EX-101.PRE 11708
6 EXTRACTED XBRL INSTANCE DOCUMENT d303262d8k_htm.xml XML 3469
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39402 | Film No.: 22588287
SIC: 2834 Pharmaceutical Preparations